HIV/AIDS anti-retroviral drug allegedly infringing Irish patent, claims US-based company

A company selling a version of an anti-retroviral drug used in the treatment of people living with HIV/AIDS is breaching the Irish patent for the product, it is claimed in Commercial Court proceedings.

US-based ViiV Healthcare Company and Japan-based Shionogi & Co Ltd, a partnership established between pharma giants GlaxoSlmithKline and Pfizer, is suing Gilead Sciences Inc, of Delaware, USA, and its Irish subsidiary Gilead Sciences Ireland UC of Carrigtwohill, Co Cork.